Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

NCT05335434 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myeloablative Allogeneic Hematopoietic Cell Transplantation
Intraoral Photobiomodulation Therapy
Oral Mucositis
Mucosal Ulcer

Interventions

DEVICE: THOR LX2.3 with LED Lollipop

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]